Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

The Lancet

Volumn 345, Issue 8947, 1995, Pages 456-457

  Chakos, MirandaH ^a   Lieberman, JeffreyA ^b   Alvir, Jose ^b   Bilder, Robert ^b   Ashtari, Manzar ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; BASAL GANGLION; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RESISTANCE; HUMAN; LETTER; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0028963319     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90441-7     Document Type: Letter

References (3)

1. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
2. Changes in caudate volume with neuroleptic treatment
3. Computerized volume mensuration of brain structure